CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients.

Chavaz L, Royston L, Masouridi-Levrat S, Mamez AC, Giannotti F, Morin S, Van Delden C, Chalandon Y, Neofytos D

Open source

DOI
10.1093/ofid/ofad169
Published
2023 Apr
Container
Open forum infectious diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ofid/ofad169,
  title = {CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients.},
  author = {Chavaz L and Royston L and Masouridi-Levrat S and Mamez AC and Giannotti F and Morin S and Van Delden C and Chalandon Y and Neofytos D},
  year = {2023},
  journal = {Open forum infectious diseases},
  doi = {10.1093/ofid/ofad169},
  url = {https://doi.org/10.1093/ofid/ofad169}
}

RIS

TY  - JOUR
TI  - CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients.
AU  - Chavaz L
AU  - Royston L
AU  - Masouridi-Levrat S
AU  - Mamez AC
AU  - Giannotti F
AU  - Morin S
AU  - Van Delden C
AU  - Chalandon Y
AU  - Neofytos D
PY  - 2023
JO  - Open forum infectious diseases
DO  - 10.1093/ofid/ofad169
UR  - https://doi.org/10.1093/ofid/ofad169
ER  - 

APA

L, C., L, R., S, M., AC, M., F, G., S, M., C, V. D., Y, C., & D, N. (2023). CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients.. Open forum infectious diseases. https://doi.org/10.1093/ofid/ofad169

Source records